Abstract
This study is to evaluate the clinical characteristics and outcomes of Enterococcus raffinosus bacteremia in adults. We analyzed the medical records of adult patients with E. raffinosus bacteremia who were diagnosed and treated between 1997 and 2020 at a tertiary care teaching hospital in Seoul, Republic of Korea. The demographic, clinical, and laboratory data were collected and assessed. A total of 49 cases of E. raffinosus bacteremia were identified. E. raffinosus accounted for 0.6% of all enterococcal bacteremia events, and the incidence was 0.02 cases per 1,000 admissions. Of the 49 cases of E. raffinosus bacteremia, 35 (71.4%) had underlying malignancy. The biliary tract was the most common source of infection (81.6%, 40/49) and polymicrobial bacteremia was found in 25 cases (51.0%). The resistance rates of E. raffinosus bacteremia cases to penicillin, ampicillin, vancomycin, and linezolid were 61.2%, 49.0%, 2.0%, and 0%, respectively. In our case series, there was one case of vanA-type vancomycin-resistant E. raffinosus. The all-cause 60-day mortality rate was 22.4% (11/49), and the E. raffinosus bacteremia-related mortality rate was 4.1% (2/49). Cases of E. raffinosus bacteremia mainly originated from biliary tract infection and had a low rate of bacteremia-related mortality.
Similar content being viewed by others
References
García-Solache M, Rice LB (2019) The enterococcus: a model of adaptability to its environment. Clin Microbiol Rev 32 (2)
Genus Enterococcus, https://lpsn.dsmz.de/genus/enterococcus. Cited October 21, 2021
Choi SH, Lee SO, Kim TH, Chung JW, Choo EJ, Kwak YG, Kim MN, Kim YS, Woo JH, Ryu J, Kim NJ (2004) Clinical features and outcomes of bacteremia caused by Enterococcus casseliflavus and Enterococcus gallinarum: analysis of 56 cases. Clin Infect Dis 38(1):53–61
Na S, Park HJ, Park KH, Cho OH, Chong YP, Kim SH, Lee SO, Sung H, Kim MN, Jeong JY, Kim YS, Woo JH, Choi SH (2012) Enterococcus avium bacteremia: a 12-year clinical experience with 53 patients. Eur J Clin Microbiol Infect Dis 31(3):303–310
Ryu BH, Hong J, Jung J, Kim MJ, Sung H, Kim MN, Chong YP, Kim SH, Lee SO, Kim YS, Woo JH, Choi SH (2019) Clinical characteristics and treatment outcomes of Enterococcus durans bacteremia: a 20-year experience in a tertiary care hospital. Eur J Clin Microbiol Infect Dis 38(9):1743–1751
Collins MD, Facklam RR, Farrow JA, Williamson R (1989) Enterococcus raffinosus sp. nov., Enterococcus solitarius sp. nov. and Enterococcus pseudoavium sp. nov. FEMS Microbiol Lett 57(3):283–288
Facklam RR, Collins MD (1989) Identification of Enterococcus species isolated from human infections by a conventional test scheme. J Clin Microbiol 27(4):731–734
Dalal A, Urban C, Rubin D, Ahluwalia M (2008) Vancomycin-resistant Enterococcus raffinosus Endocarditis: a case report and review of literature. Infect Dis Clin Pract 16(3):144–146
Freyaldenhoven BS, Schlieper G, Lütticken R, Reinert RR (2005) Enterococcus raffinosus infection in an immunosuppressed patient: case report and review of the literature. J Infect 51(3):e121-124
Jasovich A, Ganaha MC, Ebi C, García RD, Blanco MA, Lopardo H (2008) Endocarditis due to vancomycin-resistant Enterococcus raffinosus successfully treated with linezolid: case report and review of literature. Rev Argent Microbiol 40(4):204–207
Sandoe JA, Witherden IR, Settle C (2001) Vertebral osteomyelitis caused by Enterococcus raffinosus. J Clin Microbiol 39(4):1678–1679
Friedman ND, Kaye KS, Stout JE, McGarry SA, Trivette SL, Briggs JP, Lamm W, Clark C, MacFarquhar J, Walton AL, Reller LB, Sexton DJ (2002) Health care–associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 137(10):791–797
Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL, Angus DC (2016) The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315(8):801–810
Zhong Z, Zhang W, Song Y, Liu W, Xu H, Xi X, Menghe B, Zhang H, Sun Z (2017) Comparative genomic analysis of the genus Enterococcus. Microbiol Res 196:95–105
Wilke WW, Marshall SA, Coffman SL, Pfaller MA, Edmund MB, Wenzel RP, Jones RN (1997) Vancomycin-resistant Enterococcus raffinosus: molecular epidemiology, species identification error, and frequency of occurrence in a national resistance surveillance program. Diagn Microbiol Infect Dis 29(1):43–49
Kawalec M, Kedzierska J, Gajda A, Sadowy E, Wegrzyn J, Naser S, Skotnicki AB, Gniadkowski M, Hryniewicz W (2007) Hospital outbreak of vancomycin-resistant enterococci caused by a single clone of Enterococcus raffinosus and several clones of Enterococcus faecium. Clin Microbiol Infect 13(9):893–901
Heikens E, Bonten MJM, Willems RJL (2007) Enterococcal surface protein Esp is important for biofilm formation of Enterococcus faecium E1162. J Bacteriol 189(22):8233–8240
Shankar N, Lockatell CV, Baghdayan AS, Drachenberg C, Gilmore MS, Johnson DE (2001) Role of Enterococcus faecalis surface protein Esp in the pathogenesis of ascending urinary tract infection. Infect Immun 69(7):4366–4372
Grayson ML, Eliopoulos GM, Wennersten CB, Ruoff KL, Klimm K, Sapico FL, Bayer AS, Moellering RC Jr (1991) Comparison of Enterococcus raffinosus with Enterococcus avium on the basis of penicillin susceptibility, penicillin-binding protein analysis, and high-level aminoglycoside resistance. Antimicrob Agents Chemother 35(7):1408–1412
Jolivet S, Fines-Guyon M, Nebbad B, Merle JC, Le Pluart D, Brun-Buisson C, Decousser JW, Cattoir V (2016) First nosocomial outbreak of vanA-type vancomycin-resistant Enterococcus raffinosus in France. J Hosp Infect 94(4):346–350
Yusuf E, Loens K, Jans B, Cox P, Ieven M, Goossens H (2017) The first clonal spread of vanA-positive Enterococcus raffinosus in a nursing home. J Hosp Infect 96(1):72–74
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethics approval
This study was approved by the Institutional Review Board of Asan Medical Center (IRB No. 2021–0843).
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Lee, Y.W., Lim, S.Y., Jung, J. et al. Enterococcus raffinosus bacteremia: clinical experience with 49 adult patients. Eur J Clin Microbiol Infect Dis 41, 415–420 (2022). https://doi.org/10.1007/s10096-021-04389-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-021-04389-x